The immune mechanisms of abscopal effect in radiation therapy

被引:142
作者
Grass, G. Daniel
Krishna, Niveditha
Kim, Sungjune
机构
关键词
IMMUNOGENIC CELL-DEATH; HEAT-SHOCK PROTEINS; T-CELLS; TUMOR-CELLS; CALRETICULIN EXPOSURE; IONIZING-RADIATION; LOCAL IRRADIATION; ADVANCED MELANOMA; APOPTOTIC CELLS; DNA-DAMAGE;
D O I
10.1016/j.currproblcancer.2015.10.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Radiation therapy (RT) is a cornerstone in oncologic management and is employed in various curative and palliative scenarios for local-regional control. RT is thought to locally control tumor cells by direct physical DNA damage or indirect insults from reactive oxygen species. Therapeutic effects apart from those observed at the treatment target, that is, abscopal effect, have been observed for several decades, though the underlying mechanisms regulating this phenomenon have been unclear. Accumulating evidence now suggests that the immune system is a major determinant in regulating the abscopal effect It is now evident that RT may also enhance immunologic responses to tumors by creating an in situ vaccine by eliciting antigen release from dying tumor cells. Harnessing the specificity and dynamic nature of the immune system to target tumors in conjunction with RT is an emerging field with much promise. To optimize this approach, it is important to systematically evaluate the intricacies of the host immune system, the new generation of immunotherapeutics and the RT approach. Here we will discuss the current biologic mechanisms thought to regulate the RT-induced abscopal effect and how these may be translated to the clinical setting. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:10 / 24
页数:15
相关论文
共 136 条
  • [1] Influence of locoregional radiation treatment on tumor necrosis factor-α and interleukin-6 in the serum of patients with head and neck cancer
    Akmansu, M
    Unsal, D
    Bora, H
    Elbeg, S
    [J]. CYTOKINE, 2005, 31 (01) : 41 - 45
  • [2] Genetic and Phenotypic Diversity in Breast Tumor Metastases
    Almendro, Vanessa
    Kim, Hee Jung
    Cheng, Yu-Kang
    Goenen, Mithat
    Itzkovitz, Shalev
    Argani, Pedram
    van Oudenaarden, Alexander
    Sukumar, Saraswati
    Michor, Franziska
    Polyak, Kornelia
    [J]. CANCER RESEARCH, 2014, 74 (05) : 1338 - 1348
  • [3] PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
    Ansell, Stephen M.
    Lesokhin, Alexander M.
    Borrello, Ivan
    Halwani, Ahmad
    Scott, Emma C.
    Gutierrez, Martin
    Schuster, Stephen J.
    Millenson, Michael M.
    Cattry, Deepika
    Freeman, Gordon J.
    Rodig, Scott J.
    Chapuy, Bjoern
    Ligon, Azra H.
    Zhu, Lili
    Grosso, Joseph F.
    Kim, Su Young
    Timmerman, John M.
    Shipp, Margaret A.
    Armand, Philippe
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) : 311 - 319
  • [4] Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
    Apetoh, Lionel
    Ghiringhelli, Francois
    Tesniere, Antoine
    Obeid, Michel
    Ortiz, Carla
    Criollo, Alfredo
    Mignot, Gregoire
    Maiuri, M. Chiara
    Ullrich, Evelyn
    Saulnier, Patrick
    Yang, Huan
    Amigorena, Sebastian
    Ryffel, Bernard
    Barrat, Franck J.
    Saftig, Paul
    Levi, Francis
    Lidereau, Rosette
    Nogues, Catherine
    Mira, Jean-Paul
    Chompret, Agnes
    Joulin, Virginie
    Clavel-Chapelon, Francoise
    Bourhis, Jean
    Andre, Fabrice
    Delaloge, Suzette
    Tursz, Thomas
    Kroemer, Guido
    Zitvogel, Laurence
    [J]. NATURE MEDICINE, 2007, 13 (09) : 1050 - 1059
  • [5] Radiation and the microenvironment - Tumorigenesis and therapy
    Barcellos-Hoff, MH
    Park, C
    Wright, EG
    [J]. NATURE REVIEWS CANCER, 2005, 5 (11) : 867 - 875
  • [6] C1q enhances IFN-γ production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells
    Baruah, Paramita
    Dumitriu, Ingrid E.
    Malik, Talat H.
    Cook, H. Terence
    Dyson, Julian
    Scott, Diane
    Simpson, Elizabeth
    Botto, Marina
    [J]. BLOOD, 2009, 113 (15) : 3485 - 3493
  • [7] Bezu L, 2015, FRONT IMMUNOL, P6
  • [8] Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
    Brahmer, Julie
    Reckamp, Karen L.
    Baas, Paul
    Crino, Lucio
    Eberhardt, Wilfried E. E.
    Poddubskaya, Elena
    Antonia, Scott
    Pluzanski, Adam
    Vokes, Everett E.
    Holgado, Esther
    Waterhouse, David
    Ready, Neal
    Gainor, Justin
    Aren Frontera, Osvaldo
    Havel, Libor
    Steins, Martin
    Garassino, Marina C.
    Aerts, Joachim G.
    Domine, Manuel
    Paz-Ares, Luis
    Reck, Martin
    Baudelet, Christine
    Harbison, Christopher T.
    Lestini, Brian
    Spigel, David R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) : 123 - 135
  • [9] Tumor-induced perturbations of cytokines and immune cell networks
    Burkholder, Brett
    Huang, Ren-Yu
    Burgess, Rob
    Luo, Shuhong
    Jones, Valerie Sloane
    Zhang, Wenji
    Lv, Zhi-Qiang
    Gao, Chang-Yu
    Wang, Bao-Ling
    Zhang, Yu-Ming
    Huang, Ruo-Pan
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2014, 1845 (02): : 182 - 201
  • [10] The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
    Burnette, Byron C.
    Liang, Hua
    Lee, Youjin
    Chlewicki, Lukasz
    Khodarev, Nikolai N.
    Weichselbaum, Ralph R.
    Fu, Yang-Xin
    Auh, Sogyong L.
    [J]. CANCER RESEARCH, 2011, 71 (07) : 2488 - 2496